Update: FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch
Source: FDA Drug Safety Podcasts - Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
More News: Burns | Drugs & Pharmacology | Food and Drug Administration (FDA) | Headache | Migraine | Podcasts